DakoCytomation and ViroNovative enter licensing agreement on Human Metapneumovirus
DakoCytomation A/S and ViroNovative BV have entered into a licensing agreement for the development and sales of diagnostic products for the detection of Human Metapneumovirus.
Human metapneumovirus was discovered by a team of scientists led by Prof. Dr. Ab Osterhaus at the Erasmus Medical Centre, who examined samples from young children with respiratory tract infections that tested negative for known viruses. HMPV infects people of all ages, but tends to cause more severe respiratory tract infections in young children, the elderly and immunocompromised patients.
Based on the agreement DakoCytomation will have a non-exclusive, non-transferable, royalty-bearing license to develop, manufacture and sell products worldwide relating to human metapneumovirus. The field of use is limited to either direct immunofluorescence assay or a PNA technology based assay. ViroNovative has filed patent applications, and owns substantial know-how and materials relating to HMPV technology.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.